Cargando…

Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance

Cyclosporin A (CSA) suppresses immune function by blocking the cyclophilin A and calcineurin/NFAT signaling pathways. In addition to immunosuppression, CSA has also been shown to have a wide range of effects in the cardiovascular system including disruption of heart valve development, smooth muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Raghav, Botros, Mark A., Nacev, Benjamin A., Albig, Allan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361394/
https://www.ncbi.nlm.nih.gov/pubmed/25775018
http://dx.doi.org/10.1371/journal.pone.0119279
_version_ 1782361627431010304
author Pandey, Raghav
Botros, Mark A.
Nacev, Benjamin A.
Albig, Allan R.
author_facet Pandey, Raghav
Botros, Mark A.
Nacev, Benjamin A.
Albig, Allan R.
author_sort Pandey, Raghav
collection PubMed
description Cyclosporin A (CSA) suppresses immune function by blocking the cyclophilin A and calcineurin/NFAT signaling pathways. In addition to immunosuppression, CSA has also been shown to have a wide range of effects in the cardiovascular system including disruption of heart valve development, smooth muscle cell proliferation, and angiogenesis inhibition. Circumstantial evidence has suggested that CSA might control Notch signaling which is also a potent regulator of cardiovascular function. Therefore, the goal of this project was to determine if CSA controls Notch and to dissect the molecular mechanism(s) by which CSA impacts cardiovascular homeostasis. We found that CSA blocked JAG1, but not Dll4 mediated Notch1 NICD cleavage in transfected 293T cells and decreased Notch signaling in zebrafish embryos. CSA suppression of Notch was linked to cyclophilin A but not calcineurin/NFAT inhibition since N-MeVal-4-CsA but not FK506 decreased Notch1 NICD cleavage. To examine the effect of CSA on vascular development and function, double transgenic Fli1-GFP/Gata1-RFP zebrafish embryos were treated with CSA and monitored for vasculogenesis, angiogenesis, and overall cardiovascular function. Vascular patterning was not obviously impacted by CSA treatment and contrary to the anti-angiogenic activity ascribed to CSA, angiogenic sprouting of ISV vessels was normal in CSA treated embryos. Most strikingly, CSA treated embryos exhibited a progressive decline in blood flow that was associated with eventual collapse of vascular luminal structures. Vascular collapse in zebrafish embryos was partially rescued by global Notch inhibition with DAPT suggesting that disruption of normal Notch signaling by CSA may be linked to vascular collapse. However, multiple signaling pathways likely cause the vascular collapse phenotype since both cyclophilin A and calcineurin/NFAT were required for normal vascular function. Collectively, these results show that CSA is a novel inhibitor of Notch signaling and vascular function in zebrafish embryos.
format Online
Article
Text
id pubmed-4361394
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43613942015-03-23 Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance Pandey, Raghav Botros, Mark A. Nacev, Benjamin A. Albig, Allan R. PLoS One Research Article Cyclosporin A (CSA) suppresses immune function by blocking the cyclophilin A and calcineurin/NFAT signaling pathways. In addition to immunosuppression, CSA has also been shown to have a wide range of effects in the cardiovascular system including disruption of heart valve development, smooth muscle cell proliferation, and angiogenesis inhibition. Circumstantial evidence has suggested that CSA might control Notch signaling which is also a potent regulator of cardiovascular function. Therefore, the goal of this project was to determine if CSA controls Notch and to dissect the molecular mechanism(s) by which CSA impacts cardiovascular homeostasis. We found that CSA blocked JAG1, but not Dll4 mediated Notch1 NICD cleavage in transfected 293T cells and decreased Notch signaling in zebrafish embryos. CSA suppression of Notch was linked to cyclophilin A but not calcineurin/NFAT inhibition since N-MeVal-4-CsA but not FK506 decreased Notch1 NICD cleavage. To examine the effect of CSA on vascular development and function, double transgenic Fli1-GFP/Gata1-RFP zebrafish embryos were treated with CSA and monitored for vasculogenesis, angiogenesis, and overall cardiovascular function. Vascular patterning was not obviously impacted by CSA treatment and contrary to the anti-angiogenic activity ascribed to CSA, angiogenic sprouting of ISV vessels was normal in CSA treated embryos. Most strikingly, CSA treated embryos exhibited a progressive decline in blood flow that was associated with eventual collapse of vascular luminal structures. Vascular collapse in zebrafish embryos was partially rescued by global Notch inhibition with DAPT suggesting that disruption of normal Notch signaling by CSA may be linked to vascular collapse. However, multiple signaling pathways likely cause the vascular collapse phenotype since both cyclophilin A and calcineurin/NFAT were required for normal vascular function. Collectively, these results show that CSA is a novel inhibitor of Notch signaling and vascular function in zebrafish embryos. Public Library of Science 2015-03-16 /pmc/articles/PMC4361394/ /pubmed/25775018 http://dx.doi.org/10.1371/journal.pone.0119279 Text en © 2015 Pandey et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pandey, Raghav
Botros, Mark A.
Nacev, Benjamin A.
Albig, Allan R.
Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance
title Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance
title_full Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance
title_fullStr Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance
title_full_unstemmed Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance
title_short Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance
title_sort cyclosporin a disrupts notch signaling and vascular lumen maintenance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361394/
https://www.ncbi.nlm.nih.gov/pubmed/25775018
http://dx.doi.org/10.1371/journal.pone.0119279
work_keys_str_mv AT pandeyraghav cyclosporinadisruptsnotchsignalingandvascularlumenmaintenance
AT botrosmarka cyclosporinadisruptsnotchsignalingandvascularlumenmaintenance
AT nacevbenjamina cyclosporinadisruptsnotchsignalingandvascularlumenmaintenance
AT albigallanr cyclosporinadisruptsnotchsignalingandvascularlumenmaintenance